Azuma K K, Hensley C B, Tang M J, McDonough A A
Department of Physiology and Biophysics, University of Southern California School of Medicine, Los Angeles 90033.
Am J Physiol. 1993 Sep;265(3 Pt 1):C680-7. doi: 10.1152/ajpcell.1993.265.3.C680.
The purpose of this study was to determine the pattern of thyroid hormone (triiodothyronine, T3) regulation of the Na(+)-K(+)-adenosinetriphosphatase (Na(+)-K(+)-ATPase) alpha- and beta-subunit expression in skeletal muscle, which expresses alpha 1-, alpha 2-, beta 1-, and beta 2-subunits, and compare it with that seen in kidney, which expresses only alpha 1 and beta 1. Three steady states were studied: hypothyroid, euthyroid, and hyperthyroid (hypothyroids injected daily with 1 microgram T3/g body wt for 2-16 days). Protein and mRNA abundance, determined by Western and Northern analysis, were normalized to a constant amount of homogenate protein and total RNA, respectively. In skeletal muscle, there was no change in alpha 1- or beta 1-mRNA or protein levels in the transition from hypothyroid to hyperthyroid. However, alpha 2 was highly regulated; mRNA reached a new steady-state level of fivefold over hypothyroid by 8 days of T3 treatment and protein abundance increased threefold. In addition, beta 2-mRNA and protein were detected in skeletal muscle and were also highly regulated by T3; beta 2-mRNA increased nearly fourfold over hypothyroid level, and beta 2-protein abundance increased over twofold. In kidney in the transition from hypothyroid to hyperthyroid, there were coordinate 1.6-fold increases in both alpha 1- and beta 1-mRNA abundance that predicted the observed changes in alpha 1- and beta 1-protein levels and Na(+)-K(+)-ATPase activity.(ABSTRACT TRUNCATED AT 250 WORDS)
本研究的目的是确定甲状腺激素(三碘甲状腺原氨酸,T3)对骨骼肌中钠钾 - 三磷酸腺苷酶(Na(+)-K(+)-ATPase)α和β亚基表达的调节模式,骨骼肌表达α1、α2、β1和β2亚基,并将其与仅表达α1和β1的肾脏中的调节模式进行比较。研究了三种稳态:甲状腺功能减退、甲状腺功能正常和甲状腺功能亢进(甲状腺功能减退的动物每天注射1微克T3/克体重,持续2 - 16天)。通过蛋白质免疫印迹法(Western分析)和Northern印迹法测定的蛋白质和mRNA丰度,分别相对于匀浆蛋白和总RNA的恒定含量进行标准化。在骨骼肌中,从甲状腺功能减退转变为甲状腺功能亢进时,α1或β1的mRNA或蛋白质水平没有变化。然而,α2受到高度调节;T3处理8天时,mRNA达到比甲状腺功能减退时高五倍的新稳态水平,蛋白质丰度增加了三倍。此外,在骨骼肌中检测到β2 - mRNA和蛋白质,它们也受到T3的高度调节;β2 - mRNA比甲状腺功能减退水平增加了近四倍,β2 - 蛋白质丰度增加了两倍多。在从甲状腺功能减退转变为甲状腺功能亢进的肾脏中,α1和β1的mRNA丰度协同增加了1.6倍,这预测了观察到的α1和β1蛋白质水平以及钠钾 - 三磷酸腺苷酶活性的变化。(摘要截短至250字)